NEO R&D Expenses
Neogenomics Inc · R&D Expenses
NEO R&D Expenses
Latest reported$38.17Mperiod ending
NEO TTM R&D Expenses ($0.00 → $38.17M)
TTM R&D Expenses
High-resolution chart · PNG
NEO r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 38,168,000 | |
| 36,430,000 | |
| 37,077,000 | |
| 35,867,000 | |
| 34,857,000 | |
| 33,720,000 | |
| 31,159,000 | |
| 30,317,000 | |
| 27,918,000 | |
| 27,534,000 | |
| 27,309,000 | |
| 26,857,000 | |
| 28,884,000 | |
| 34,308,000 | |
| 39,526,000 | |
| 41,364,000 | |
| 41,461,000 | |
| 32,030,000 | |
| 21,873,000 | |
| 15,460,000 | |
| 10,015,000 | |
| 8,625,000 | |
| 8,229,000 | |
| 8,209,000 | |
| 8,856,000 | |
| 9,338,000 | |
| 8,487,000 | |
| 6,933,000 | |
| 4,768,000 | |
| 3,254,000 | |
| 3,001,000 | |
| 3,031,000 | |
| 3,855,000 | |
| 3,729,000 | |
| 3,635,000 | |
| 4,009,000 | |
| 3,706,000 | |
| 4,065,000 | |
| 4,649,000 | |
| 5,575,000 | |
| 5,479,000 | |
| 4,976,000 | |
| 4,199,000 | |
| 2,757,000 | |
| 2,900,000 | |
| 2,730,000 | |
| 2,689,000 | |
| 2,924,000 | |
| 2,250,000 | |
| 2,233,000 | |
| 2,440,000 | |
| 2,239,000 | |
| 2,707,000 | |
| 2,619,000 | |
| 2,281,000 | |
| 1,833,000 | |
| 1,150,000 | |
| 794,000 | |
| 297,000 | |
| 297,000 | |
| 172,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 8,175 | |
| 20,399 | |
| 35,657 | |
| 53,381 | |
| 45,206 | |
| 32,982 | |
| 17,724 | |
| 0 | |
| 0 | |
| 0 |